Author: admin

  • Powell's last Jackson Hole speech could pack a punch – Reuters

    1. Powell’s last Jackson Hole speech could pack a punch  Reuters
    2. Federal Reserve Bank of Kansas City to Host Annual Jackson Hole Economic Policy Symposium Aug. 21-23  Kansas City – Federal Reserve
    3. Jay Powell to deliver Jackson Hole address under fire on multiple fronts  Financial Times
    4. Which sectors will fall if the Fed delivers a hawkish surprise at Jackson Hole?  Investing.com
    5. US 10-Year Yield Inches Down  TradingView

    Continue Reading

  • Fungicide use may be placing canola production at risk

    Fungicide use may be placing canola production at risk

    Dr Steve Marcroft inspects canola growing in a trial site. Photo: Marcroft Grains Pathology

    CROP pathologists and fungal disease experts are concerned about the increasing use of precautionary fungicide applications in Australian canola.

    Repeated applications of a single fungicide as “cheap insurance” against disease could have serious long-term consequences.

    Australian Fungicide Resistance Extension Network (AFREN) project lead Fran Lopez-Ruiz, said fungicide resistance posed an ongoing threat to canola production, with frequent and repeated application of the same fungicide group being one of the main drivers.

    AFREN is an initiative of the Grains Research and Development Corporation.

    “Repeated use of fungicides from the same chemical group, especially when there’s no clear evidence of yield benefit, can drive the development of fungicide resistance within disease populations,” Dr Lopez-Ruiz said.

    Fungicide resistance means a fungicide is no longer effective for disease control and denies growers the option to use the affected fungicide group.

    This loss increases reliance on other registered fungicide groups, increasing the risk of multiple fungicide resistance scenarios.

    Spores released by fungicide-resistant fungi can spread over large areas in a short time.

    This means overuse of fungicides and poor disease management practices on a single farm can quickly become a regional problem.

    “We are seeing this with net form net blotch (NFNB) of barley in parts of South Australia, Western Australia and Victoria.”

    “NFNB pathogen populations with triple fungicide resistance to all three registered fungicide groups have limited growers’ options for protecting their barley yields.

    “This is why AFREN recommends a targeted approach to fungicide application – only apply fungicide when necessary and when there is a clear economic benefit from doing so.

    “Even then, different fungicide groups should always be used in rotation so any pathogens with fungicide resistance or reduced sensitivity will be controlled by one of the treatments.”

    The comparison between NFNB of barley and blackleg of canola should not be taken lightly, according to Steve Marcroft of Marcroft Grains Pathology, based in Horsham, Vic.

    Blackleg with reduced sensitivity to Group 3 fungicides prothioconazole, fluquinconazole, flutriafol and tebuconazole is present in NSW, SA, Vic and WA.

    There is a high likelihood of resistance developing with the potential for field failure in pathogen-conducive environments.

    Mutations for reduced sensitivity to Group 7 SDHI fungicides and Group 12 fungicide fludioxonil, the only other fungicide groups registered for blackleg control, have also been detected in SA.

    There is a potential for reduced sensitivity to these two groups under high disease and fungicide selection pressure.

    Dr Marcroft said he has received several inquiries about using double rates or off-label timings to help control blackleg or mitigate efficacy issues due to fungicide resistance.

    “Both practices are illegal, as label rates and requirements must be followed, and they will also contribute to increased levels of fungicide resistance,” Dr Marcroft said.

    “Fungicides must only be applied in accordance with label recommendations and only used when disease pressure is high and there is a clear risk of yield loss.”

    Preliminary results from GRDC-supported research by Marcroft Grains Pathology, using blackleg of canola as a model, suggests that foliar applications during the four to eight-leaf stage are the main driver of fungicide resistance.

    Canola plants can typically tolerate crown canker infection of up to 20 per cent before any yield loss occurs. Photo: Marcroft Grains Pathology

    Growers should avoid spraying fungicide during this growth stage if possible.

    “It’s important to remember that canola plants can tolerate a significant amount of disease before any yield loss occur,  typically up to 20 percent crown canker infection,” Dr Marcroft said.

    “While skipping early foliar applications will lead to a small amount of crown canker, this is unlikely to result in yield losses but will have a massive impact on minimising the risk of fungicide resistance evolving.”

    Low levels of Upper Canopy Infection (UCI) are also unlikely to impact yield. Furthermore, applying fungicide after 50 per cent bloom can breach maximum residue limit (MRL) restrictions.

    “If fungicides are used to excess when disease pressure is low or there is no threat to yields, they may no longer be effective when we genuinely need them,” Dr Marcroft said.

    “What may seem like cheap insurance now could actually be a longer-term risk to canola production. Weighing the pros and cons of a fungicide spray with your agronomist is a much better investment.”

    Growers should also follow the AFREN Fungicide Resistance 5 principles for integrated disease management.

    This includes planting canola at least 500m from the previous season’s stubble, using time of sowing to manage disease risk, and using more resistant varieties and rotating them.

    The AFREN website contains further information.

    Source: GRDC

    Continue Reading

  • ‘Playing the Prime Minister ‘changes your perception’ of politics’ says Suranne Jones

    ‘Playing the Prime Minister ‘changes your perception’ of politics’ says Suranne Jones

    Netflix Suranne Jones as Abigail Dalton in Netflix's Hostage. She stands outside no10 downing street waving and smiling Netflix

    Jones says she was ‘a bit of a geek’ when it came to researching the role and spent many hours in the House of Commons and talking to politicians

    Actress Suranne Jones has taken on the role of many women under immense pressure. In Doctor Foster she suspects her husband of having an affair, in Vigil she investigates a death on board a submarine, and in Gentleman Jack she develops a dangerous lesbian romance.

    But none of the roles are quite as pressured as her latest – playing a British prime minister whose husband is kidnapped.

    Hostage, Netflix’s new political thriller, sees Jones’ character, Abigail Dalton, build an uneasy alliance with French President Vivienne Toussaint – played by Julie Delpy – who is being blackmailed during a London summit.

    The two leaders work together in order to rescue the PM’s husband, unmask the kidnapper and blackmailer, and bring those responsible to justice.

    ‘Political with a small p’

    Given its themes of immigration, the funding of the NHS and public trust, audiences may be tempted to connect Hostage to today’s headlines.

    But, both stars insist the show is less about mirroring today’s politics and more about creating a thrilling story set in the political world.

    “We’re entertaining and we’re in the political world, but it’s in no way a reflection of the world we live in,” Jones tells the BBC.

    “It’s political with a small p – there’s enough that roots us in the real world but the world is too complicated to link it directly and I think it would be inappropriate.”

    Delpy agrees and says: “Things change every day. It’s impossible to be in the political moment because tomorrow is something else.”

    The show’s writer, Matt Charman, explains that there are some connections to the real world as it’s “impossible to write a show that exists in the climate we live in that doesn’t end up feeling that it’s in dialogue with it”.

    “If you wrote a show that isn’t connected to our world it would feel weird,” he says, “but I hope the show does have the ability to exist in its own oxygen.”

    Netflix Suranne Jones and Julie Delpy in character standing outside no10 downing street in front of lecterns Netflix

    Charman specifically wanted the two leaders in hostage to be women

    It is rare to see two female world leaders sharing the spotlight in a political thriller, but, for Charman, making sure Dalton and Toussaint were women was integral to the way the series was conceived and it was both a creative and political choice.

    “What was exciting was the idea of women in power and how we explore that,” he says, explaining that he tried to explore how each situation the characters face would be different for a woman.

    “There’s a double standard for women, so giving full dramatic freedom to that was very important.”

    Charman and Jones have shared an agent for the past 10 years and Hostage came about because Charman really wanted to work with Jones and the pair settled on creating a political thriller.

    Jones says she particularly enjoyed exploring “how these two women have to dance around each other”.

    “A female politician is used to dealing with men so it’s interesting to see how it plays out when it’s two women.”

    While viewers quickly learn about Jones’ character – a loving wife and mother who is idealistic about bettering the country – Delpy’s character is more drawn out and our opinion of her changes throughout the show.

    “We made sure not to play into the female politician stereotypes,” Delpy say. “What I like is that these women actually have some things in common like they both want change and came into office hopeful.”

    The Guardian describe Hostage as “quite unusual” in that it doesn’t remind you of any other political thrillers.

    “It’s a little biting but it’s not House of Cards cynical, it has a breakneck pace but it’s not 24, the dialogue is sharp but never played for laughs,” Zoe Williams writes.

    ‘Cost of being in power’

    To play Dalton convincingly, Jones, who also served as an executive producer on the show, says she really immersed herself in the reality of political life. She visited the House of Commons, spoke to the Speaker of the House and devoured books, podcasts and documentaries.

    “I’m a bit of a geek when it comes to research,” she admits. “I was fascinated by not emulating anyone but by understanding a life I knew nothing about. And it’s the cost of being in a powerful position in that way that really struck me.”

    Charman also talks about the extraordinary amount of research that went into creating the show.

    I ask him whether Dalton or Toussaint were inspired by any real life politicians and he confesses that they are, but he won’t say who.

    “We interviewed a lot of people and Suranne had incredible access to people who had been prime minister who talked about their time in office and the pressure on their family. But it was all agreed that they would speak about this as long as it could remain confidential,” he says.

    Jones won’t say which politicians inspired her character but says all of her previous characters are a part of her and she has “a boardroom of personalities” which feed into who she plays.

    She says all the research into what it’s like to be a politician “changes your perception for sure” and makes you realise “the cost of being in a powerful position”.

    Netflix Ashley Thomas looking scared as two masked men push himNetflix

    Ashley Thomas plays the Prime Minister’s husband who is kidnapped in French Guiana

    One question the show raises is whether or not it’s possible for a politician today to stick to their ideals once they come into office and while Jones is unsure, Charman is an optimist.

    “I wanted to explore how there can be decent people in politics who are fundamentally good but get pushed around,” he says.

    He adds that it’s not “inevitable” that people give up their ideals once in office, but “it’s definitely tough to keep your morals”.

    Above the thrills and drama of Hostage, Charman says the show explores “what it takes to be a good person in a system that doesn’t always reward good people.”

    Delpy is slightly more pessimistic and explains that given “politicians have to be heard, if you’re too reasonable you won’t be listened to as there’s so much noise of both extremes”.

    “If you have a moderate view you get lost in the noise as people are only listening to the loudest.”

    Continue Reading

  • Rock Used as Doorstop For Decades Found to Be Worth Over $1 Million : ScienceAlert

    Rock Used as Doorstop For Decades Found to Be Worth Over $1 Million : ScienceAlert

    They say one person’s trash is another’s treasure, but a chunk of ‘rock’ used to keep a door open for decades is a treasure by almost anyone’s standards.

    A woman discovered the 3.5-kilogram (7.7-pound) stone in a stream bed in southeast Romania, brought it home, and used it as a doorstop.

    Her find turned out to be one of the biggest intact chunks of amber in the world, according to a report by El Pais. Its value? Somewhere in the region of €1 million – around US$1.1 million.

    Related: Man Keeps a Rock For Years Hoping It’s Gold. It Turns Out to Be Far More Valuable.

    Resin forming under the damaged branch of a tree. (KevinDyer/Canva)

    Amber is tree resin from millions of years in the past. Over time, the highly viscous substance fossilizes into a hard, warm-hued material widely recognized as a gemstone.

    In Romania, pieces of amber can be found around the village of Colti in sandstone from the banks of the River Buzau, where it has been mined since the 1920s.

    Known as rumanite, this amber is famed and prized for its wide array of deep, reddish hues.

    YouTube Thumbnail frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share” referrerpolicy=”strict-origin-when-cross-origin” allowfullscreen>

    The elderly woman who found this particular rumanite nugget lived in Colti, where it remained performing a function so humble that it was missed even by jewel thieves who once targeted the home, reports say.

    After the woman died in 1991, the relative who inherited her home suspected the doorstop might be more than meets the eye. On learning what he had, he sold the amber to the Romanian state, which had it appraised by experts at the Museum of History in Krakow in Poland.

    According to these experts, the amber is likely around 38 to 70 million years old.

    The chunk of amber. (Buzău County Museum)

    “Its discovery represents a great significance both at a scientific level and at a museum level,” Daniel Costache, director of the Provincial Museum of Buzau, told El Pais.

    Classified as a national treasure of Romania, the nugget has had a home at the Provincial Museum of Buzau – the county in which the relic was found – since 2022.

    An ant inside a block of amber
    An ant inside Baltic amber. (Anders L. Damgaard/CC BY-SA 4.0/Wikimedia Commons)

    The discovery resembles that of a man in Michigan, who kept a large piece of rock as a doorstop, only to find out decades later that he was keeping his doors in place with a meteorite worth $100,000.

    A chunk of amber worth over a million dollars isn’t a bad score, either, really. Just imagine how many doorstops you could buy.

    An earlier version of this article was published in September 2024.

    Continue Reading

  • India’s biofuel drive is saving billions but also sparking worries

    India’s biofuel drive is saving billions but also sparking worries

    Getty Images A petrol pump worker, in a saffron dress, putting fuel in a bike. The pumping machine can be seen in the background.

Getty Images

    Indian government says ethanol blending has cut 69.8 million tonnes of carbon dioxide emissions since 2014

    India’s drive to blend more biofuels with petrol has helped the country cut millions of tonnes of carbon dioxide emissions and save precious dollar reserves.

    But it has also sparked worries among vehicle owners and food policy experts about its potential impact on fuel efficiency and food security.

    Last month, India achieved its objective of blending 20% ethanol with petrol, known as E20, five years ahead of its target.

    The government views this as a game changer in reducing carbon emissions and trimming oil imports. Since 2014, ethanol blending has helped India cut 69.8 million tonnes of carbon dioxide emissions and saved 1.36 trillion rupees ($1.5 bn; £1.1 bn) in foreign exchange.

    A study by Delhi-based think tank Council on Energy, Environment and Water (CEEW) shows that carbon dioxide emissions from road transport in India will nearly double by 2050.

    “The demand for fuel is only going to increase and shifting to ethanol-blended petrol is absolutely necessary to cut down emissions,” Sandeep Theng from the Indian Federation of Green Energy, an organisation that promotes green energy, told the BBC.

    But many vehicles in India are not E20-compliant, making their owners sceptical about the benefits of the policy.

    Hormazd Sorabjee, editor of Autocar India magazine, said that ethanol has a “lower energy density than petrol and is more corrosive”. This results in lower mileage and exposes certain vehicle parts to a greater risk of wear and tear.

    Mr Sorabjee added that some manufacturers like Honda have been using E20 compliant material since 2009, but many older vehicles on Indian roads are not E20 compatible.

    While there is no official data on the impact of of E20 fuel on engines, consumers routinely share anecdotes about their vehicle’s deteriorating mileage on social media.

    Many standard insurance policies in India also don’t provide cover for damage due to the use of non-compliant fuel, a top executive at online insurance platform Policybazaar, who wanted to stay anonymous, told the BBC.

    “Consumers need to take add-on policies but even those claims can be denied or downgraded based on fine print of the policy,” he added.

    The federal petroleum ministry has described these concerns as “largely unfounded”.

    In a post on X, the ministry said that engine tuning and E20-compatible materials could minimise the drop in mileage. It also advised replacing certain parts in older vehicles, saying the process was inexpensive and “easily done during regular servicing of the vehicle”.

    Getty Images A worker, wearing turquoise-white checked shirt and blue jeans, inside a factory, working with stubble. 
Getty Images

    Expansion of ethanol use could mean diverting more farm produce into manufacturing fuel

    Mr Sorabjee told the BBC that while milage concerns are real, they are a “not always as bad as made out to be”.

    The bigger concern, he said, was the potential damage to vehicle materials due to the corrosive properties of E20.

    Some vehicle manufacturers are offering ways to mitigate this.

    Maruti Suzuki, India’s biggest four-wheeler maker, is reportedly likely to introduce an E20 material kit that could cost up to 6,000 rupees ($69; £51). The kit will reportedly replace components like fuel lines, seals and gaskets. Bajaj, a leading Indian two-wheeler maker, has advised using a fuel cleaner that could cost around 100 rupees ($1.15; £0.85) for a full tank of petrol.

    But not all vehicle-owners are convinced. Amit Pandhi, who has owned a Maruti Suzuki car in Delhi since 2017, is unhappy that petrol pumps don’t offer the choice to opt for a blend other than E20.

    “Why should I be forced to buy petrol that offers less mileage and then spend more to make the materials compliant?” he asked.

    In 2021, a document on India’s transition to E20 published by Niti Aayog, a government think tank, had highlighted some of these concerns. It recommended tax benefits for buying E20 compliant vehicles, along with a lower retail price for the fuel.

    The government has defended its decision to not pass the recommendations, saying that at the time of the report’s relase, ethanol was cheaper than petrol.

    “Over time, procurement price of ethanol has increased and now the weighted average price of ethanol is higher than cost of refined petrol,” the petroleum ministry said earlier this month.

    Getty Images India's federal Minister of Petroleum and Natural Gas Hardeep Singh Puri, wearing blue jacket and turban, with his hand raised, is addressing a gathering. Getty Images

    India is looking to increase ethanol-blending in petrol in the coming years

    It’s not just consumers – the government’s blended fuel push has also raised concern among climate researchers and food policy experts.

    Ethanol is produced from crops like sugarcane and maize, and expanding its use means diverting farm produce into manufacturing more fuel.

    In 2025, India would need 10 billion litres of ethanol to meet its E20 requirements, according to government estimates. The demand will balloon to 20 billion litres by 2050, according to Bengaluru-based think tank Center for Study of Science, Technology and Policy (CSTEP).

    Right now, sugarcane is used to produce about 40% of India’s ethanol.

    This puts India in a bind. It has to choose between continuing its reliance on sugarcane – which has a higher yield for ethanol but is water-intensive – or using food crops like maize and rice to produce the fuel.

    But the shift comes with its own challenges.

    In 2024, for the first time in decades, India became a net importer of maize, using large amounts of the crop to make ethanol.

    Ramya Natarajan, a research scientist at CSTEP, said the diversion of produce had a significant impact on the poultry sector, which now has to spend more to buy corn for feedstock.

    Moreover, this year, the Food Corporation of India (FCI) approved an unprecedented allocation of 5.2 million tonnes of rice for ethanol production. The rice in FCI stocks is earmarked to be given to India’s poor at a subsidised rate.

    The policy could lead to an “agriculture disaster in a couple of years”, said Devinder Sharma, a farming sector expert.

    “In a country like India, where 250 million people go hungry, we cannot use food to feed the cars,” Mr Sharma said.

    To meet the demand for ethanol through corn and sugarcane in a 50-50 ratio – as outlined by Niti Aayog – India would have to bring in an additional eight million hectares of land under maize cultivation by 2030, unless there is a drastic increase in yield, according to CSTEP.

    But even that could lead to problems.

    “If farmers replace rice or wheat cultivation with maize, that would be sustainable because we have enough surplus of these crops. But we need other crops like oilseeds and pulses too,” Ms Natarajan said.

    Ms Natarajan added that continuing with the E10 blend – petrol mixed with 10% ethanol – would have been a more ideal choice.

    India, however, is planning to go even beyond E20.

    “The country will now gradually scale towards E25, E27, and E30 in a phased, calibrated manner,” Petroleum Minister Hardeep Puri said recently.

    Follow BBC News India on Instagram, YouTube, X and Facebook


    Continue Reading

  • ‘The Summer I Turned Pretty’ actor breaks down latest episode of series

    ‘The Summer I Turned Pretty’ actor breaks down latest episode of series



    The Summer I Turned Pretty’s Sean Kaufman opens up about the latest episode

    The Summer I Turned Pretty’s Sean Kaufman is opening up about the latest episode, weighing in on the debate surrounding the show’s ‘stressful’ love triangle.

    Kaufman, who portrays Steven in the series, is getting candid about the romantic dilemma in the third and final season.

    During an exclusive interview with People magazine, the actor recently explained why he found himself torn between the two women in his life.

    He told the outlet, “I had no idea what to expect. When we started season 3, we weren’t given all the scripts, so to go episode by episode and see how it plays out, and see the love triangle start to form, was very interesting and fun.”

    The 25-year-old broke down the latest episode, revealing how the love story begins to wrap up in the final installment of the series.

    Speaking about the August 20 episode, Kaufman said, “Yeah, it’s a big one. It’s the first time you see the dynamic between the three of them.”

    For those unfamiliar, the actor stars alongside Rain Spencer and Denise in the series’ central love triangle.

    Continue Reading

  • Google Beats Apple in Smartphone AI Race

    Google Beats Apple in Smartphone AI Race

    Apple is behind Google in the race to add artificial intelligence (AI) features to smartphones, according to Wall Street Journal Personal Tech Columnist Nicole Nguyen.

    An iPhone user, Nguyen wrote Wednesday (Aug. 20) that her experience with Google’s upcoming Pixel 10 showed that Google has “lapped” Apple as both companies work to develop the “killer AI-powered phone.”

    Nguyen highlighted the Pixel 10’s AI-powered ability to surface information when needed, provide translations via a real-time voice clone and transcript, coach users to take good photos, and edit photos that have already been taken.

    “The race continues and for now, Apple has a lot of catching up to do,” Nguyen wrote.

    Apple did not immediately reply to PYMNTS’ request for comment.

    PYMNTS CEO Karen Webster wrote July 23 that Apple faces the risk of its iPhone becoming a commodity because the Pixel 9 has, and Pixel 10 will ship with, embedded AI that lets users speak, search, transact and navigate with a native AI experience.

    “Apple can’t match that today,” Webster wrote. “The risk is how many consumers will keep waiting around for Apple to deliver. It’s a massive pain to switch from iOS to Android devices, and most people don’t. Getting an AI-powered Android device just may be enough for people to dump their iPhones.”

    Apple has faced AI challenges that include investor impatience, talent departures and delayed Siri upgrades, as PYMNTS has chronicled in recent months.

    It was reported Aug. 14 that the company is preparing a comeback in the AI space that includes a redesigned Siri powered by large language models, which could potentially arrive on iPhones and iPads as early as next year.

    Apple’s hardware pipeline also includes thinner iPhones this year.

    On Aug. 4, it was reported that Apple held a rare companywide meeting to cover its investment in AI and that CEO Tim Cook expressed a positive outlook about the company’s AI future.

    According to the report, Cook told workers that Apple has “exciting” plans for AI that he wasn’t able to discuss.

    Earlier, during an earnings call, Cook said the company is making “good progress” on integrating more AI capabilities in Siri.

    Continue Reading

  • CJ rejects delay in Imran bail hearings

    CJ rejects delay in Imran bail hearings


    ISLAMABAD:

    Chief Justice Yahya Afridi on Wednesday made it clear that the Supreme Court would not allow prolonged adjournments in the bail petitions of PTI founder Imran Khan, being heard in connection with multiple cases linked to the May 9, 2023 violence.

    A three-member bench led by Chief Justice Afridi, and including Muhammad Shafi Siddiqui and Justice Miangul Hasan Aurangzeb, took up appeals against the Lahore High Court’s (LHC) June 24 decision, in which a bench led by Justice Shahbaz Ali Rizvi had dismissed Imran’s bail applications.

    During the proceedings, the chief justice observed that the prosecution would first have to cross the threshold of establishing how the LHC’s rejection of the bail could be sustained. “We will hear the prosecution first,” he remarked.

    The hearing began with an assisting counsel informing the bench that Special Prosecutor Zulfiqar Naqvi could not appear due to food poisoning and was currently admitted to a hospital. He requested the matter be adjourned until next week.

    The chief justice, however, responded that the matter would be taken up on Thursday (today). Advocate Salman Safdar, representing the PTI founder, objected to the adjournment request and urged the court to at least allow them to argue.

    He pointed out that the LHC had dismissed his client’s bail plea in November last year after six months of pendency, during which 16 hearings were held and eight different prosecutors were changed. “The prosecution repeatedly sought adjournments. We are now fed up,” he said.

    Chief Justice Afridi assured the defence that the matter would not be subjected to unnecessary delays. Advocate Safdar requested that family members of the PTI founder, who were present in court, be allowed to address the bench.

    However, the chief justice declined the request, stating: “We will only hear the lawyer. We will not allow family members to speak in court.” The hearing was attended by the PTI founder’s sisters along with senior party leaders. Later, the bench adjourned further proceedings until Thursday (today).

    In their detailed verdict, LHC’s Justice Syed Shahbaz Ali Rizvi and Justice Tariq Mahmood Bajwa had said: “In this view of the matter argument furnished by learned counsel for the petitioner (Imran Khan) to the effect that on May 9, 2023, the petitioner was in jail is of no help to him.”

    In its detailed verdict, the bench reproduced the statements of two police officials, the prosecution witnesses, who claimed to have secretly attended the meetings of the PTI wherein the party’s founder allegedly gave instructions to other party leaders to attack military installations in case of his imminent arrest from the IHC.

    The bench observed that the statements of the witnesses were not to be termed as belated.

    It said the role assigned to the petitioner, evident from the statements of the witnesses, attracted the provisions of Section 120-B (punishment for criminal conspiracy) and 121-A (conspiracy to commit offence of waging or attempting to wage war against the country) of the Pakistan Penal Code.

    The bench held that the statements of the witnesses prima facie reflected that the conspiracy and abetment for the offences committed on May 9 were perpetrated by the petitioner on May 4 at Chakri rest area, Rawalpindi, on May 7 and on May 9 at Lahore.

    Continue Reading

  • Strong commercial performance enables investment for long-term growth

    Strong commercial performance enables investment for long-term growth

    Telix Therapeutics: Reinvesting earnings to accelerate late-stage pipeline

    Of the total R&D investment, 54% ($43.9 million) was invested in the therapeutics pipeline. Milestones achieved include:

    • TLX591 (177Lu-rosopatamab tetraxetan): Completed target enrollment of 30 patients for Part 1 of the Phase 3 study in advanced metastatic castration resistant prostate cancer (mCRPC). The trial has received regulatory approval to proceed in Australia, China, Canada, New Zealand, Turkey and Japan.

    • TLX592 (225Ac-PSMA-RADmAb): Approval to commence a Phase 1, first-in-human therapeutic study of a targeted alpha therapy in advanced mCRPC.

    • TLX101 (131I-iodofalan, or 131I-IPA): Approval to commence IPAX BrIGHT, an international pivotal trial, to commence at Australian sites initially.

    • TLX090 (153Sm-DOTMP): Investigational New Drug (IND) application approved for a Phase 1 bridging study for Telix’s therapeutic candidate for the palliation of bone pain in patients with osteoblastic metastatic disease to the bone.

    Commentary

    Managing Director and Group CEO, Dr. Christian Behrenbruch, commented on the result:

    “Telix continues to deliver strong revenue growth while building a foundation for the future. The first half of 2025 was a period of rapid transformation as we expanded our global manufacturing operations, invested in launching new products in new markets, and accelerated the development of our therapeutic pipeline. These investments have positioned Telix for sustainable, long-term growth, while our diversified business provides multiple drivers of success. To generate future revenue growth, we are confident in securing product approvals for Pixclara and Zircaix while advancing geographic and indication expansion for the PSMA portfolio.”

    Summary Group financial results

     

    H1 2025

    H1 2024

     

    US$M

    US$M

    Revenue

    390.4

     

    239.6

     

    Cost of sales

    (181.8

    )

    (82.4

    )

    Gross profit

    208.6

     

    157.2

     

    Research and development (R&D)

    (81.6

    )

    (55.4

    )

    Selling and marketing

    (49.0

    )

    (24.6

    )

    Manufacturing and distribution

    (18.8

    )

    (8.4

    )

    General and administration

    (47.7

    )

    (39.2

    )

    Other losses (net)

    (1.1

    )

    (1.9

    )

    Operating profit

    10.4

     

    27.7

     

    Finance income

    3.6

     

    0.9

     

    Finance costs

    (18.8

    )

    (5.7

    )

    (Loss)/profit before tax

    (4.8

    )

    22.9

     

    Adjusted EBITDA

    21.1

     

    37.1

     

    Cash from operating activities

    17.7

     

    23.3

     


    Guidance

    • Telix confirms FY 2025 revenue guidance of US$770 million to US$800 million11.

    • Guidance reflects revenue from Illuccix sales in jurisdictions with a marketing authorization, and 11 months of revenue contribution from RLS12.

    • Telix confirms R&D expenditure guidance, expecting a year-over-year increased investment range for FY 2025 of 20% to 25% compared to FY 2024.

    lnvestor call

    An investor webcast and conference call will be held at 9.30am AEST on Thursday 21 August 2025 (7.30pm EDT Wednesday 20 August 2025).

    Participants can register for the webcast by clicking here: https://edge.media-server.com/mmc/p/x4gytx8w/ or the teleconference here: https://s1.c-conf.com/diamondpass/10049152-x745re.html

    About Telix Pharmaceuticals Limited

    Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Canada, Europe (Belgium and Switzerland), Brazil and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

    Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

    Telix Investor Relations (Global)

    Ms. Kyahn Williamson
    Telix Pharmaceuticals Limited
    SVP Investor Relations and Corporate Communications
    Email: kyahn.williamson@telixpharma.com

    Telix Investor Relations (U.S.)

    Ms. Annie Kasparian
    Telix Pharmaceuticals Limited
    Director Investor Relations and Corporate Communications
    Email: annie.kasparian@telixpharma.com

    Guidance Disclaimer

    The stated revenue guidance is based on expected global and domestic economic conditions and is subject to known and unknown risks, uncertainties and other factors that may cause our actual results to differ materially. As such, investors are cautioned not to place undue reliance on this guidance and in particular Telix cannot guarantee a particular result. In compiling financial forecasts, a number of key variables that may have a significant impact on guidance have been identified and are listed below.

    Key variables that could cause actual results to differ materially include: the success and timing of research and development activities; decisions by regulatory authorities regarding approval of our products as well as their decisions regarding label claims; competitive developments affecting our products; the ability to successfully market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pricing, reimbursement, access or tax; acquisitions and divestitures; research collaborations; litigation or government investigations; and Telix’s ability to protect its patents and other intellectual property.

    This announcement has been authorized for release by the Telix Pharmaceuticals Limited Board of Directors

    Legal Notices

    Cautionary Statement Regarding Forward-Looking Statements.

    You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

    The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

    This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context
    of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

    Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

    ©2025 Telix Pharmaceuticals Limited. All rights reserved.

    1. See summary Group financial results table at end of this document.

    2. Group performance includes Telix Precision Medicine, Telix Therapeutics and Telix Manufacturing Solutions (TMS).

    3. All comparisons to H1 2024 results.

    4. FY 2025 revenue guidance of US$770 million to US$800 million.

    5. Earnings before interest, tax, depreciation and amortization.

    6. Increased investment range for FY 2025 expected to be 20% to 25% compared to FY 2024.

    7. Launch and brand names subject to final regulatory approval.

    8. RLS network is comprised of 28 locations across the U.S.

    9. Positron emission tomography.

    10. Single photon emission computed tomography.

    11. Refer to ASX disclosures 20 February 2025.

    12. See Guidance Disclaimer for further information.

    Continue Reading

  • This surprising gas could be causing deep seafloor earthquakes

    This surprising gas could be causing deep seafloor earthquakes

    Deep beneath the Mid-Atlantic Ridge, scientists have recorded earthquakes at roughly 6 to 12 miles below the seafloor, far deeper than where rock should normally crack. The finding points to a new driver of seismicity far from familiar fault zones and volcanoes.

    The culprit is not extra cold rock or a hidden megafault. It looks like carbon dioxide in hot mantle melt changing volume as pressure drops, a physical nudge that can make rock fail at depth.

    Deep seafloor earthquakes


    A research team deployed ocean-bottom seismometers, autonomous instruments that sit on the seafloor and record tiny vibrations, during the SMARTIES campaign in 2019.

    Those sensors captured clusters of microearthquakes in the warm mantle directly under the ridge axis, well below the usual brittle layer. 

    The work was led by Satish C. Singh of the Institut de Physique du Globe de Paris (IPGB), a group with decades of experience imaging the oceanic crust and mantle.

    In this study, the team focused on a slow-spreading equatorial ridge segment where seismic activity is usually modest.

    Geochemical analyses of nearby basalts showed unusually high carbon dioxide in the primary melts, about 0.4 to 3.0 percent by weight. That enrichment is consistent with melts derived from a mantle source that carries extra volatiles. 

    The earthquakes sit at depths where temperatures are expected to be too high for rock to break in a brittle way. That mismatch pushed the team to look beyond temperature or fault geometry and consider the physical effects of gases in magma.

    How CO2 triggers seafloor earthquakes

    Degassing changes the volume of a fluid, and in a confined rock, even small pressure shifts can matter.

    The solubility of CO2 in basaltic melt depends strongly on pressure, so as melt rises and pressure falls, bubbles form and the melt expands. 

    At depth, CO2 can stay dissolved at high concentrations, then separate as a gas as pressure eases, a process that stiffens and relaxes stresses along cracks in quick bursts.

    Volatile solubility studies show this pressure control is a first-order effect in mafic magmas. 

    Seismologists often use mantle temperatures around 700 to 900 degrees Celsius as a practical ceiling for where brittle failure can occur, which puts these Atlantic events in notably hot conditions.

    That is why a stress source tied to expanding gas, not a cold, thick lid, better fits the observations.

    Why it matters for ocean crust

    Volatiles do more than spark eruptions at volcanoes on land. They lower melting temperatures, steer where melts collect, and change how the new ocean crust forms beneath spreading ridges.

    The Atlantic results suggest volatiles can also shape where and how earthquakes happen in the mantle beneath ridges. 

    If CO2 rich melts stall in the mantle before feeding the crust, they can evolve chemically and mechanically at depth.

    That pause can increase heterogeneity in the lithosphere, the rigid outer shell, and near the asthenosphere, the weaker layer below it.

    The study also helps explain seismic reflections and partial melt hints right at the lithosphere, asthenosphere boundary in the equatorial Atlantic.

    Independent work indicates that a small percentage of melt, aided by volatiles, can persist there at temperatures below the dry peridotite solidus.

    What makes this different from volcano swarms

    Deep earthquakes linked to magma motion show up in active volcanic zones like Iceland’s Reykjanes Peninsula.

    There, researchers documented deep long period events at about 6 to 7 miles depth around the 2021 Fagradalsfjall eruption, a very different tectonic setting. 

    Off Mayotte in the Indian Ocean, a seismic crisis revealed drainage of a huge reservoir from roughly 15 to 22 miles down, accompanied by deformation and very long period signals.

    That sequence pointed to a developing submarine volcano rather than steady ridge accretion.

    In Iceland’s Northern Volcanic Zone, several nests of unusually deep quakes, sometimes deeper than 20 miles, are tied to magma movement below the usual brittle layer.

    Those cases involve thickened crust and a volcanic plumbing system, unlike the Atlantic ridge segment studied here.

    Fresh look at volatile-rich ridges

    The Atlantic ridge segment examined spreads slowly, a regime where melt pathways are complex and tectonics can expose mantle rocks on the seafloor.

    In such settings, volatile rich melts may focus and linger, priming the conditions for gas driven stress changes at depth.

    Global ridge studies show that mid ocean ridge basalt glasses are commonly depleted in CO2 by the time they erupt, which complicates efforts to reconstruct their original volatile content.

    Trace element ratios such as CO2 to Ba and CO2 to Rb provide workarounds to estimate the pre-eruptive load.

    More deep seafloor earthquakes studies

    Better constraints on volatile content and pressure in the mantle will come from longer deployments and denser arrays of seafloor instruments.

    Targeted sampling of fresh basalts and melt inclusions will tighten the links between chemistry, pressure, and the mechanics of these deep events.

    Models that couple gas solubility, fracture mechanics, and ridge thermal structure can test how much CO2 is needed to tip rock into failure in hot mantle.

    Those models can also explain why only some ridge segments host deep quakes while others stay quiet.

    The study is published in Nature Communications.

    —–

    Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

    Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

    —–

    Continue Reading